Healthtech is a topic tracked in our intelligence system with 5 linked articles.
Samsung reveals two AI foundation models to learn from smartwatch biosignals as part of a Connected Care vision announced at Galaxy Unpacked 2026.
STAT+ profiles Commure’s $7B AI-driven push to automate healthcare administration and the challenging realities behind the ambitious quest.
CMS/FDA detail a RAPID pathway for breakthrough devices, and nurses push back on AI, signaling regulatory and workforce-policy implications for market access.
TandemStride targets a $1B wedge within a $5–$10B TAM for recovery infrastructure after traumatic health events, focusing on patients leaving acute care.
A dense venture-capital digest of Oct 29, 2019 highlighting dozens of funding rounds and notable regulatory/legal moves (WhatsApp-NSO suit, Juul exec lawsuit, Uber-L.A. data dispute), plus IPOs, exits, and new fundraisings across tech, biotech, fintech, and real estate platforms.
Open-source diabetes software outside FDA oversight reportedly improves glucose control and is free/on iPhone, but regulatory risk grows as updates outpace FDA review.
Subscribe for real-time topic updates and unlimited access to our intelligence platform.